IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Scott who wrote (1426)	1/18/1998 9:41:00 PM
From: Roger Cranwill	of 1762

Scott-As a pharmacist, I can tell you exactly what insurance companies are interested in-the most "bang" for the lowest "buck". When we bill online for medications, the diagnosis is never asked-only does the drug in question reside in that insurance company's specific formulary. If it doesn't (another way to read that is "too expensive" for the desired patient outcome), then the doctor has to fill out paperwork getting special authorization-its normally given, but the imposition of additional paperwork is incentive for staying within the scope of the formulary. To summarize, the real question is if the drug is in the insurance company's formulary. Period. Roger

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next